Australia markets closed

Danaher Corporation (DHR)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
223.31+0.79 (+0.36%)
At close: 04:03PM EST
223.31 0.00 (0.00%)
Pre-market: 08:41AM EST

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees79,000

Key executives

NameTitlePayExercisedYear born
Mr. Steven M. RalesCo-Founder & ChairmanN/AN/A1951
Mr. Rainer M. BlairPresident, CEO & Director5.93M5.83M1964
Mr. Mitchell P. RalesCo-Founder & DirectorN/AN/A1957
Mr. Matthew R. McGrewCFO & Executive VP2.85M4.12M1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer2.24MN/A1963
Mr. Joakim WeidemanisExecutive Vice President3.13M6.28M1969
Mr. Christopher M. BoudaVP & Chief Accounting OfficerN/AN/AN/A
Mr. John BedfordVice President of Investor RelationsN/AN/AN/A
Mr. Brian W. EllisSenior VP, General Counsel & Chief Compliance Officer1.93MN/A1967
Mr. Daniel A. Raskas J.D.Senior Vice President of Corporate DevelopmentN/AN/A1967
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Corporate governance

Danaher Corporation’s ISS governance QualityScore as of 28 November 2023 is 7. The pillar scores are Audit: 8; Board: 10; Shareholder rights: 3; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.